Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cerebral Palsy | 26 | 2013 | 62 | 4.440 |
Why?
|
Orthopedics | 13 | 2022 | 90 | 2.650 |
Why?
|
Neuromuscular Agents | 10 | 2012 | 29 | 1.840 |
Why?
|
Hand | 19 | 2012 | 66 | 1.820 |
Why?
|
Fingers | 19 | 2021 | 64 | 1.760 |
Why?
|
Muscle Spasticity | 12 | 2013 | 24 | 1.610 |
Why?
|
Muscle, Skeletal | 11 | 2011 | 518 | 1.380 |
Why?
|
Orthopedic Procedures | 6 | 2022 | 89 | 1.320 |
Why?
|
Ischemia | 9 | 2021 | 98 | 1.320 |
Why?
|
Range of Motion, Articular | 14 | 2015 | 187 | 1.310 |
Why?
|
Complex Regional Pain Syndromes | 5 | 2016 | 19 | 1.200 |
Why?
|
Humans | 123 | 2022 | 32024 | 1.160 |
Why?
|
Upper Extremity | 5 | 2015 | 57 | 1.140 |
Why?
|
Tendon Transfer | 3 | 2018 | 16 | 1.000 |
Why?
|
Diagnosis | 2 | 2016 | 3 | 0.970 |
Why?
|
Arm | 7 | 2010 | 37 | 0.970 |
Why?
|
External Fixators | 3 | 2011 | 15 | 0.940 |
Why?
|
Conflict of Interest | 7 | 2016 | 35 | 0.890 |
Why?
|
Sympathectomy | 8 | 2021 | 21 | 0.880 |
Why?
|
Physician's Role | 2 | 2016 | 40 | 0.860 |
Why?
|
Cold Temperature | 13 | 2011 | 50 | 0.860 |
Why?
|
Arterial Occlusive Diseases | 4 | 2008 | 35 | 0.800 |
Why?
|
Finger Joint | 4 | 2018 | 12 | 0.780 |
Why?
|
Child | 28 | 2013 | 2441 | 0.740 |
Why?
|
Self Concept | 2 | 2016 | 42 | 0.740 |
Why?
|
Reflex Sympathetic Dystrophy | 6 | 2004 | 11 | 0.740 |
Why?
|
Male | 75 | 2016 | 19195 | 0.720 |
Why?
|
Veins | 5 | 2008 | 29 | 0.700 |
Why?
|
Quality of Life | 11 | 2013 | 932 | 0.690 |
Why?
|
Raynaud Disease | 5 | 2011 | 9 | 0.660 |
Why?
|
Dupuytren Contracture | 1 | 2018 | 2 | 0.620 |
Why?
|
Hand Deformities, Acquired | 1 | 2018 | 3 | 0.620 |
Why?
|
Injections, Intramuscular | 14 | 2013 | 42 | 0.620 |
Why?
|
Electromyography | 5 | 2011 | 59 | 0.620 |
Why?
|
Internship and Residency | 1 | 2022 | 314 | 0.600 |
Why?
|
Adolescent | 28 | 2015 | 3526 | 0.590 |
Why?
|
Hand Injuries | 3 | 2010 | 23 | 0.590 |
Why?
|
Botulinum Toxins | 6 | 2008 | 38 | 0.580 |
Why?
|
Physician-Patient Relations | 6 | 2013 | 185 | 0.560 |
Why?
|
Musculoskeletal Diseases | 2 | 2008 | 37 | 0.550 |
Why?
|
Tibial Fractures | 3 | 2011 | 31 | 0.540 |
Why?
|
Aftercare | 1 | 2016 | 33 | 0.520 |
Why?
|
Neuromuscular Blockade | 3 | 2001 | 6 | 0.520 |
Why?
|
Neuromuscular Junction | 5 | 2015 | 72 | 0.500 |
Why?
|
Child, Preschool | 15 | 2013 | 1269 | 0.500 |
Why?
|
Patient Care Planning | 1 | 2016 | 59 | 0.500 |
Why?
|
Peripheral Vascular Diseases | 3 | 2008 | 35 | 0.490 |
Why?
|
Wrist Injuries | 6 | 2011 | 43 | 0.490 |
Why?
|
Female | 52 | 2016 | 19953 | 0.490 |
Why?
|
Laser-Doppler Flowmetry | 13 | 2011 | 31 | 0.480 |
Why?
|
Muscle Tonus | 2 | 2011 | 4 | 0.480 |
Why?
|
Pain, Postoperative | 3 | 2015 | 179 | 0.470 |
Why?
|
Equinus Deformity | 3 | 2003 | 4 | 0.460 |
Why?
|
Osteotomy | 2 | 2010 | 51 | 0.460 |
Why?
|
Patient Care | 6 | 2008 | 31 | 0.450 |
Why?
|
Body Temperature Regulation | 12 | 2003 | 22 | 0.450 |
Why?
|
Contracture | 5 | 2008 | 16 | 0.450 |
Why?
|
Rats, Sprague-Dawley | 14 | 2012 | 745 | 0.450 |
Why?
|
Postoperative Complications | 8 | 2016 | 785 | 0.450 |
Why?
|
Animals | 35 | 2013 | 7466 | 0.440 |
Why?
|
Fracture Fixation | 2 | 2011 | 35 | 0.440 |
Why?
|
Treatment Outcome | 16 | 2015 | 3317 | 0.440 |
Why?
|
Thrombosis | 4 | 2008 | 73 | 0.430 |
Why?
|
Social Responsibility | 1 | 2013 | 12 | 0.430 |
Why?
|
Nerve Regeneration | 5 | 2013 | 48 | 0.420 |
Why?
|
Clinical Protocols | 1 | 2013 | 99 | 0.420 |
Why?
|
Disabled Children | 2 | 2003 | 19 | 0.420 |
Why?
|
Ear | 8 | 2000 | 18 | 0.420 |
Why?
|
Clubfoot | 2 | 2008 | 3 | 0.410 |
Why?
|
Receptors, Nicotinic | 3 | 2007 | 59 | 0.410 |
Why?
|
Rats | 15 | 2012 | 1596 | 0.410 |
Why?
|
Radial Artery | 3 | 2008 | 16 | 0.400 |
Why?
|
Joint Deformities, Acquired | 2 | 2010 | 12 | 0.400 |
Why?
|
Peripheral Nerves | 4 | 2011 | 62 | 0.400 |
Why?
|
Radius Fractures | 4 | 2015 | 60 | 0.400 |
Why?
|
Birth Injuries | 2 | 2010 | 28 | 0.390 |
Why?
|
Adult | 32 | 2016 | 9366 | 0.390 |
Why?
|
Brachial Plexus Neuropathies | 2 | 2010 | 36 | 0.390 |
Why?
|
Neurologic Examination | 2 | 2008 | 28 | 0.390 |
Why?
|
Vascular Surgical Procedures | 3 | 2008 | 90 | 0.380 |
Why?
|
Military Medicine | 1 | 2011 | 24 | 0.370 |
Why?
|
Replantation | 3 | 2001 | 10 | 0.370 |
Why?
|
Muscle Strength | 3 | 2011 | 161 | 0.370 |
Why?
|
GAP-43 Protein | 2 | 2007 | 6 | 0.370 |
Why?
|
Keratins | 4 | 2013 | 39 | 0.370 |
Why?
|
Femoral Fractures | 1 | 2011 | 40 | 0.360 |
Why?
|
Knee Joint | 5 | 2008 | 142 | 0.360 |
Why?
|
Follow-Up Studies | 14 | 2015 | 2280 | 0.360 |
Why?
|
Ulnar Artery | 2 | 2008 | 4 | 0.360 |
Why?
|
Muscle Contraction | 6 | 2013 | 114 | 0.350 |
Why?
|
Online Systems | 2 | 2000 | 12 | 0.350 |
Why?
|
Neurosurgical Procedures | 2 | 2015 | 99 | 0.350 |
Why?
|
Middle Aged | 28 | 2015 | 11868 | 0.350 |
Why?
|
Wrist | 4 | 1998 | 48 | 0.350 |
Why?
|
Specialties, Surgical | 1 | 2010 | 28 | 0.350 |
Why?
|
Fractures, Bone | 3 | 2006 | 148 | 0.350 |
Why?
|
Pain | 4 | 2005 | 288 | 0.340 |
Why?
|
Shoulder Joint | 2 | 2010 | 126 | 0.340 |
Why?
|
Prospective Studies | 10 | 2022 | 2283 | 0.340 |
Why?
|
Microcirculation | 18 | 2012 | 65 | 0.330 |
Why?
|
Foot Ulcer | 1 | 2008 | 3 | 0.330 |
Why?
|
Psychomotor Disorders | 1 | 2008 | 4 | 0.320 |
Why?
|
Bone Transplantation | 3 | 1997 | 45 | 0.320 |
Why?
|
Arteries | 5 | 2021 | 67 | 0.320 |
Why?
|
Median Nerve | 2 | 2013 | 51 | 0.320 |
Why?
|
Myogenic Regulatory Factors | 2 | 2007 | 8 | 0.320 |
Why?
|
Leg | 2 | 2000 | 66 | 0.320 |
Why?
|
Wounds and Injuries | 2 | 2016 | 253 | 0.320 |
Why?
|
Tissue Scaffolds | 4 | 2013 | 415 | 0.310 |
Why?
|
Hemophilia A | 1 | 2008 | 25 | 0.310 |
Why?
|
Neuromuscular Junction Diseases | 1 | 2007 | 4 | 0.300 |
Why?
|
Thrombocythemia, Essential | 1 | 2007 | 2 | 0.300 |
Why?
|
Carpal Tunnel Syndrome | 3 | 2015 | 62 | 0.300 |
Why?
|
Achilles Tendon | 1 | 2007 | 22 | 0.300 |
Why?
|
Amputation, Traumatic | 3 | 2001 | 11 | 0.280 |
Why?
|
Ultrasonography | 7 | 2016 | 379 | 0.280 |
Why?
|
United States | 8 | 2022 | 3938 | 0.280 |
Why?
|
Fracture Fixation, Internal | 3 | 2002 | 116 | 0.280 |
Why?
|
Rabbits | 15 | 2011 | 196 | 0.280 |
Why?
|
Paresis | 1 | 2006 | 13 | 0.270 |
Why?
|
Finger Injuries | 1 | 2006 | 8 | 0.270 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2007 | 58 | 0.270 |
Why?
|
Dose-Response Relationship, Drug | 8 | 2013 | 629 | 0.270 |
Why?
|
Finger Phalanges | 1 | 2006 | 7 | 0.270 |
Why?
|
Equipment Design | 4 | 2013 | 172 | 0.260 |
Why?
|
Gene Expression Regulation | 2 | 2007 | 494 | 0.260 |
Why?
|
Regional Blood Flow | 13 | 2012 | 86 | 0.260 |
Why?
|
Osteogenesis, Distraction | 2 | 2006 | 19 | 0.260 |
Why?
|
Disability Evaluation | 5 | 2015 | 240 | 0.250 |
Why?
|
Tendons | 4 | 2013 | 59 | 0.250 |
Why?
|
Analgesia | 1 | 2005 | 29 | 0.250 |
Why?
|
Medicaid | 2 | 2002 | 94 | 0.250 |
Why?
|
Skin | 6 | 1998 | 210 | 0.240 |
Why?
|
Vasoconstriction | 6 | 2000 | 41 | 0.240 |
Why?
|
Pseudarthrosis | 2 | 1997 | 8 | 0.240 |
Why?
|
Pain Measurement | 6 | 2011 | 351 | 0.240 |
Why?
|
Arthroscopy | 7 | 2011 | 239 | 0.230 |
Why?
|
Industry | 3 | 2008 | 15 | 0.230 |
Why?
|
Health Care Sector | 3 | 2008 | 18 | 0.230 |
Why?
|
Foot Deformities, Acquired | 2 | 1994 | 6 | 0.230 |
Why?
|
Ulnar Nerve | 1 | 2003 | 23 | 0.220 |
Why?
|
RNA, Messenger | 3 | 2013 | 508 | 0.220 |
Why?
|
Depressive Disorder, Major | 1 | 2003 | 42 | 0.210 |
Why?
|
Motor Neurons | 1 | 2002 | 56 | 0.210 |
Why?
|
Wrist Joint | 4 | 2015 | 60 | 0.210 |
Why?
|
Mothers | 1 | 2003 | 88 | 0.210 |
Why?
|
Scleroderma, Localized | 1 | 2002 | 5 | 0.210 |
Why?
|
Antitrust Laws | 1 | 2022 | 2 | 0.200 |
Why?
|
Infant | 7 | 2004 | 1061 | 0.200 |
Why?
|
Adaptation, Psychological | 1 | 2003 | 136 | 0.200 |
Why?
|
Neuronal Plasticity | 1 | 2002 | 80 | 0.200 |
Why?
|
Wound Healing | 3 | 2011 | 185 | 0.200 |
Why?
|
Tendon Injuries | 2 | 2013 | 38 | 0.200 |
Why?
|
Hemiplegia | 4 | 2011 | 13 | 0.200 |
Why?
|
Skin Temperature | 6 | 2011 | 16 | 0.200 |
Why?
|
Venous Thrombosis | 1 | 2002 | 49 | 0.200 |
Why?
|
Ligaments | 2 | 1992 | 13 | 0.190 |
Why?
|
Health Services Needs and Demand | 1 | 2002 | 81 | 0.190 |
Why?
|
North Carolina | 3 | 2022 | 1516 | 0.190 |
Why?
|
Stress, Psychological | 1 | 2003 | 218 | 0.190 |
Why?
|
Ligaments, Articular | 2 | 1999 | 49 | 0.190 |
Why?
|
Hair | 2 | 2013 | 28 | 0.190 |
Why?
|
Rotator Cuff | 2 | 2011 | 72 | 0.190 |
Why?
|
Education, Medical, Graduate | 1 | 2022 | 129 | 0.190 |
Why?
|
Surgical Flaps | 3 | 1997 | 72 | 0.190 |
Why?
|
Caregivers | 1 | 2002 | 113 | 0.180 |
Why?
|
Drug Administration Schedule | 3 | 2013 | 273 | 0.180 |
Why?
|
Ear, External | 4 | 1998 | 7 | 0.180 |
Why?
|
MEDLARS | 1 | 2000 | 1 | 0.180 |
Why?
|
Serial Publications | 1 | 2000 | 3 | 0.180 |
Why?
|
MEDLINE | 1 | 2000 | 3 | 0.180 |
Why?
|
Muscles | 4 | 2013 | 62 | 0.180 |
Why?
|
Radiography | 8 | 2011 | 377 | 0.170 |
Why?
|
Compartment Syndromes | 1 | 2000 | 39 | 0.170 |
Why?
|
Muscle Denervation | 2 | 2011 | 29 | 0.170 |
Why?
|
Analysis of Variance | 5 | 2008 | 464 | 0.170 |
Why?
|
Scaphoid Bone | 1 | 1999 | 9 | 0.160 |
Why?
|
Double-Blind Method | 3 | 2013 | 526 | 0.160 |
Why?
|
Forearm Injuries | 1 | 1999 | 8 | 0.160 |
Why?
|
Vascular Patency | 4 | 2008 | 69 | 0.160 |
Why?
|
Time Factors | 8 | 2013 | 2152 | 0.160 |
Why?
|
Radius | 1 | 1999 | 26 | 0.160 |
Why?
|
Fracture Fixation, Intramedullary | 3 | 2015 | 34 | 0.160 |
Why?
|
Retrospective Studies | 9 | 2021 | 3523 | 0.160 |
Why?
|
Vascular Diseases | 3 | 2005 | 66 | 0.160 |
Why?
|
Sensation Disorders | 1 | 1998 | 20 | 0.150 |
Why?
|
Infant, Newborn | 6 | 2003 | 673 | 0.150 |
Why?
|
Athletic Injuries | 2 | 2005 | 82 | 0.150 |
Why?
|
Animals, Newborn | 3 | 2010 | 115 | 0.150 |
Why?
|
Debridement | 3 | 2011 | 43 | 0.150 |
Why?
|
Arm Injuries | 1 | 1998 | 21 | 0.150 |
Why?
|
Gait | 4 | 2001 | 141 | 0.150 |
Why?
|
Recurrence | 4 | 2012 | 265 | 0.150 |
Why?
|
Disease Models, Animal | 7 | 2011 | 1017 | 0.150 |
Why?
|
Splints | 2 | 2010 | 13 | 0.150 |
Why?
|
Ganglia | 1 | 1997 | 1 | 0.140 |
Why?
|
Synovial Cyst | 1 | 1997 | 1 | 0.140 |
Why?
|
Tenosynovitis | 1 | 1997 | 1 | 0.140 |
Why?
|
Carpal Bones | 1 | 1997 | 16 | 0.140 |
Why?
|
Amputation | 3 | 2015 | 38 | 0.140 |
Why?
|
Microsurgery | 1 | 1997 | 19 | 0.140 |
Why?
|
Osteomyelitis | 1 | 1997 | 22 | 0.140 |
Why?
|
Anastomosis, Surgical | 4 | 2008 | 61 | 0.140 |
Why?
|
Arthritis, Infectious | 1 | 1997 | 24 | 0.140 |
Why?
|
Electrophysiological Phenomena | 2 | 2013 | 27 | 0.140 |
Why?
|
Severity of Illness Index | 2 | 2018 | 900 | 0.140 |
Why?
|
Glomus Tumor | 1 | 2016 | 4 | 0.140 |
Why?
|
Reference Values | 3 | 2013 | 247 | 0.140 |
Why?
|
Bacteremia | 1 | 1997 | 65 | 0.140 |
Why?
|
Incidence | 3 | 2016 | 1200 | 0.130 |
Why?
|
Staphylococcal Infections | 1 | 1997 | 76 | 0.130 |
Why?
|
Aging | 1 | 2002 | 945 | 0.130 |
Why?
|
Angiography | 3 | 2008 | 80 | 0.130 |
Why?
|
Axilla | 1 | 2015 | 18 | 0.130 |
Why?
|
Connective Tissue Diseases | 1 | 1995 | 7 | 0.130 |
Why?
|
Stress, Physiological | 2 | 1994 | 55 | 0.130 |
Why?
|
Ulnar Neuropathies | 1 | 2015 | 17 | 0.130 |
Why?
|
Gene Expression Profiling | 2 | 2007 | 323 | 0.130 |
Why?
|
Ketamine | 2 | 2011 | 19 | 0.120 |
Why?
|
Patient Participation | 1 | 2016 | 82 | 0.120 |
Why?
|
Evidence-Based Medicine | 2 | 2010 | 217 | 0.120 |
Why?
|
Foot | 3 | 2008 | 39 | 0.120 |
Why?
|
Bone Nails | 1 | 2015 | 32 | 0.120 |
Why?
|
Receptors, Adrenergic, alpha-1 | 3 | 2000 | 7 | 0.120 |
Why?
|
Joint Instability | 2 | 2015 | 76 | 0.120 |
Why?
|
Bone Plates | 1 | 2015 | 66 | 0.120 |
Why?
|
Casts, Surgical | 2 | 2006 | 20 | 0.120 |
Why?
|
Mice, Inbred Strains | 2 | 2011 | 47 | 0.120 |
Why?
|
Autonomic Nerve Block | 2 | 2011 | 10 | 0.120 |
Why?
|
Mice | 5 | 2011 | 2475 | 0.120 |
Why?
|
Movement Disorders | 2 | 2004 | 26 | 0.120 |
Why?
|
Physical Therapy Modalities | 2 | 2011 | 64 | 0.120 |
Why?
|
Algorithms | 2 | 2015 | 496 | 0.110 |
Why?
|
Interprofessional Relations | 3 | 2008 | 49 | 0.110 |
Why?
|
Recovery of Function | 4 | 2011 | 200 | 0.110 |
Why?
|
Foot Diseases | 1 | 1993 | 10 | 0.110 |
Why?
|
Lunate Bone | 2 | 2011 | 13 | 0.110 |
Why?
|
Muscle Relaxation | 1 | 2013 | 6 | 0.110 |
Why?
|
Prevalence | 2 | 2011 | 981 | 0.110 |
Why?
|
Models, Animal | 3 | 2008 | 164 | 0.110 |
Why?
|
Hyperhidrosis | 1 | 2012 | 5 | 0.110 |
Why?
|
Calcaneus | 1 | 1993 | 13 | 0.110 |
Why?
|
Nail Diseases | 1 | 2013 | 5 | 0.110 |
Why?
|
Sciatic Nerve | 2 | 2007 | 36 | 0.110 |
Why?
|
Cryotherapy | 1 | 1993 | 13 | 0.110 |
Why?
|
Medical History Taking | 2 | 2010 | 37 | 0.110 |
Why?
|
Bioreactors | 1 | 2013 | 60 | 0.110 |
Why?
|
Contusions | 1 | 1993 | 41 | 0.110 |
Why?
|
Functional Laterality | 2 | 2011 | 56 | 0.100 |
Why?
|
Humeral Fractures | 3 | 2002 | 34 | 0.100 |
Why?
|
Macaca fascicularis | 1 | 2013 | 397 | 0.100 |
Why?
|
Physical Examination | 2 | 2010 | 92 | 0.100 |
Why?
|
Renal Dialysis | 1 | 2015 | 279 | 0.100 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2011 | 6 | 0.100 |
Why?
|
Efferent Pathways | 1 | 2011 | 8 | 0.100 |
Why?
|
Motor Cortex | 1 | 2011 | 12 | 0.100 |
Why?
|
Observer Variation | 2 | 2009 | 105 | 0.100 |
Why?
|
Osteochondritis | 1 | 2011 | 6 | 0.100 |
Why?
|
Synovitis | 1 | 2011 | 6 | 0.100 |
Why?
|
Sweating | 1 | 2011 | 15 | 0.100 |
Why?
|
Electric Stimulation Therapy | 1 | 2011 | 14 | 0.100 |
Why?
|
Truth Disclosure | 1 | 2011 | 13 | 0.100 |
Why?
|
Aged | 10 | 2015 | 10340 | 0.100 |
Why?
|
Arthralgia | 1 | 2011 | 33 | 0.100 |
Why?
|
Sympathetic Nervous System | 1 | 2011 | 31 | 0.100 |
Why?
|
Ethics, Clinical | 2 | 2008 | 8 | 0.100 |
Why?
|
Hot Temperature | 2 | 2010 | 71 | 0.100 |
Why?
|
Anticonvulsants | 1 | 2011 | 65 | 0.100 |
Why?
|
Trisomy | 1 | 1991 | 11 | 0.100 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 1991 | 20 | 0.100 |
Why?
|
Melanoma | 1 | 2013 | 164 | 0.100 |
Why?
|
Antidepressive Agents | 1 | 2011 | 74 | 0.100 |
Why?
|
Professional Competence | 2 | 2008 | 19 | 0.090 |
Why?
|
Afghan Campaign 2001- | 1 | 2011 | 14 | 0.090 |
Why?
|
Phenol | 2 | 2008 | 6 | 0.090 |
Why?
|
Electrophysiology | 3 | 2007 | 71 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 3 | 2011 | 918 | 0.090 |
Why?
|
Delivery of Health Care | 2 | 2010 | 159 | 0.090 |
Why?
|
Abnormalities, Multiple | 1 | 1991 | 28 | 0.090 |
Why?
|
Publishing | 1 | 2011 | 60 | 0.090 |
Why?
|
Brain Mapping | 1 | 2011 | 178 | 0.090 |
Why?
|
Phonophoresis | 1 | 2010 | 1 | 0.090 |
Why?
|
X-Ray Microtomography | 1 | 2010 | 40 | 0.090 |
Why?
|
Iontophoresis | 1 | 2010 | 6 | 0.090 |
Why?
|
Femur Head Necrosis | 2 | 2001 | 10 | 0.090 |
Why?
|
Multiple Trauma | 1 | 2011 | 41 | 0.090 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 2010 | 9 | 0.090 |
Why?
|
Thumb | 2 | 1990 | 6 | 0.090 |
Why?
|
Epiphyses, Slipped | 1 | 1990 | 4 | 0.090 |
Why?
|
Analgesics | 1 | 2011 | 109 | 0.090 |
Why?
|
Reaction Time | 1 | 2011 | 117 | 0.090 |
Why?
|
Bandages | 1 | 2010 | 33 | 0.090 |
Why?
|
Hand Deformities, Congenital | 1 | 1990 | 8 | 0.090 |
Why?
|
Femur Head | 1 | 1990 | 11 | 0.090 |
Why?
|
Economic Recession | 1 | 2010 | 1 | 0.090 |
Why?
|
Relative Value Scales | 1 | 2010 | 2 | 0.090 |
Why?
|
History, 20th Century | 2 | 2002 | 71 | 0.090 |
Why?
|
Biomedical Technology | 1 | 2010 | 5 | 0.090 |
Why?
|
Adrenal Cortex Hormones | 1 | 2011 | 128 | 0.090 |
Why?
|
Health Care Rationing | 1 | 2010 | 12 | 0.090 |
Why?
|
Cicatrix | 1 | 2010 | 39 | 0.090 |
Why?
|
Periodicals as Topic | 1 | 2011 | 91 | 0.090 |
Why?
|
Skin Neoplasms | 1 | 2013 | 214 | 0.090 |
Why?
|
Synaptic Transmission | 1 | 2011 | 117 | 0.090 |
Why?
|
Kidney Failure, Chronic | 1 | 2015 | 541 | 0.090 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 261 | 0.090 |
Why?
|
Arteriovenous Anastomosis | 3 | 2000 | 4 | 0.090 |
Why?
|
Health Care Reform | 1 | 2010 | 44 | 0.090 |
Why?
|
Ankle | 2 | 2011 | 29 | 0.080 |
Why?
|
Rupture | 2 | 2007 | 34 | 0.080 |
Why?
|
Fasciitis, Plantar | 1 | 2008 | 2 | 0.080 |
Why?
|
Exocytosis | 1 | 2008 | 10 | 0.080 |
Why?
|
Injections, Intralesional | 1 | 2008 | 15 | 0.080 |
Why?
|
Neurotransmitter Agents | 1 | 2008 | 26 | 0.080 |
Why?
|
Occupational Therapy | 1 | 2008 | 4 | 0.080 |
Why?
|
Tennis Elbow | 1 | 2008 | 18 | 0.080 |
Why?
|
Health Status | 2 | 2004 | 399 | 0.080 |
Why?
|
Tibial Nerve | 1 | 2008 | 22 | 0.080 |
Why?
|
Necrosis | 1 | 2008 | 53 | 0.080 |
Why?
|
Arthroplasty, Replacement | 1 | 2008 | 17 | 0.080 |
Why?
|
Models, Biological | 1 | 2011 | 391 | 0.080 |
Why?
|
Quadriplegia | 1 | 2008 | 11 | 0.080 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2008 | 12 | 0.080 |
Why?
|
Accidents, Traffic | 1 | 2011 | 195 | 0.080 |
Why?
|
Professional Role | 1 | 2008 | 19 | 0.080 |
Why?
|
Toes | 3 | 1996 | 15 | 0.080 |
Why?
|
Paralysis | 1 | 2007 | 13 | 0.080 |
Why?
|
Gangrene | 1 | 2007 | 4 | 0.080 |
Why?
|
Decision Making | 1 | 2010 | 194 | 0.080 |
Why?
|
Diagnostic Imaging | 1 | 2008 | 94 | 0.070 |
Why?
|
Suture Techniques | 1 | 2007 | 61 | 0.070 |
Why?
|
Immobilization | 2 | 2006 | 8 | 0.070 |
Why?
|
Tissue Engineering | 1 | 2013 | 656 | 0.070 |
Why?
|
Reflex | 1 | 2007 | 15 | 0.070 |
Why?
|
Prazosin | 4 | 2012 | 9 | 0.070 |
Why?
|
Radial Nerve | 2 | 2015 | 17 | 0.070 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2006 | 8 | 0.070 |
Why?
|
Myogenin | 1 | 2006 | 4 | 0.070 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2008 | 89 | 0.070 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2006 | 18 | 0.070 |
Why?
|
Atrophy | 1 | 2006 | 46 | 0.070 |
Why?
|
Receptors, Cholinergic | 1 | 2006 | 22 | 0.070 |
Why?
|
Collateral Ligaments | 1 | 2006 | 9 | 0.070 |
Why?
|
Reproducibility of Results | 1 | 2008 | 765 | 0.070 |
Why?
|
Elbow Joint | 1 | 2007 | 63 | 0.070 |
Why?
|
Reoperation | 2 | 1997 | 227 | 0.070 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2006 | 83 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2006 | 161 | 0.070 |
Why?
|
Models, Cardiovascular | 3 | 1998 | 31 | 0.070 |
Why?
|
Biocompatible Materials | 1 | 2007 | 232 | 0.070 |
Why?
|
MyoD Protein | 1 | 2005 | 9 | 0.060 |
Why?
|
Cumulative Trauma Disorders | 1 | 2005 | 13 | 0.060 |
Why?
|
Peptide Fragments | 1 | 2008 | 398 | 0.060 |
Why?
|
Foot Deformities | 1 | 2004 | 1 | 0.060 |
Why?
|
Nerve Tissue Proteins | 1 | 2005 | 120 | 0.060 |
Why?
|
Random Allocation | 3 | 2011 | 220 | 0.060 |
Why?
|
Chronic Disease | 3 | 2011 | 401 | 0.060 |
Why?
|
Neuromuscular Blocking Agents | 2 | 1996 | 7 | 0.060 |
Why?
|
Acute Disease | 1 | 2005 | 254 | 0.060 |
Why?
|
Gene Expression | 1 | 2005 | 335 | 0.060 |
Why?
|
Parasympatholytics | 1 | 2003 | 3 | 0.060 |
Why?
|
Smoking | 3 | 2015 | 500 | 0.060 |
Why?
|
Autonomic Nervous System | 1 | 2004 | 43 | 0.060 |
Why?
|
Combined Modality Therapy | 2 | 1997 | 565 | 0.060 |
Why?
|
Membrane Proteins | 1 | 2005 | 257 | 0.060 |
Why?
|
Fractures, Spontaneous | 2 | 1997 | 16 | 0.060 |
Why?
|
Electrodiagnosis | 2 | 2015 | 42 | 0.050 |
Why?
|
Aged, 80 and over | 5 | 2015 | 4000 | 0.050 |
Why?
|
Family Health | 1 | 2003 | 76 | 0.050 |
Why?
|
Cell Count | 1 | 2002 | 47 | 0.050 |
Why?
|
Regression Analysis | 1 | 2003 | 294 | 0.050 |
Why?
|
Hip | 1 | 2002 | 15 | 0.050 |
Why?
|
Tensile Strength | 2 | 2013 | 53 | 0.050 |
Why?
|
Fee-for-Service Plans | 1 | 2002 | 12 | 0.050 |
Why?
|
History, 19th Century | 1 | 2002 | 13 | 0.050 |
Why?
|
Psoas Muscles | 1 | 2002 | 19 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2004 | 687 | 0.050 |
Why?
|
Stress, Mechanical | 2 | 2011 | 92 | 0.050 |
Why?
|
Social Support | 1 | 2003 | 179 | 0.050 |
Why?
|
History, 21st Century | 1 | 2002 | 59 | 0.050 |
Why?
|
Brachial Artery | 1 | 2002 | 69 | 0.050 |
Why?
|
Axons | 2 | 2013 | 35 | 0.050 |
Why?
|
Health Surveys | 1 | 2002 | 197 | 0.050 |
Why?
|
Vasomotor System | 2 | 1993 | 21 | 0.050 |
Why?
|
Pulmonary Embolism | 1 | 2002 | 49 | 0.050 |
Why?
|
Neural Conduction | 2 | 2013 | 91 | 0.050 |
Why?
|
Femoral Vein | 2 | 1997 | 9 | 0.050 |
Why?
|
Phenylephrine | 3 | 2000 | 28 | 0.050 |
Why?
|
Action Potentials | 2 | 2013 | 178 | 0.050 |
Why?
|
Diagnosis, Differential | 2 | 2013 | 518 | 0.050 |
Why?
|
Saphenous Vein | 1 | 2000 | 20 | 0.040 |
Why?
|
Patient Satisfaction | 1 | 2002 | 240 | 0.040 |
Why?
|
Hip Joint | 2 | 2000 | 59 | 0.040 |
Why?
|
Multimedia | 1 | 2000 | 19 | 0.040 |
Why?
|
Guided Tissue Regeneration | 2 | 2011 | 38 | 0.040 |
Why?
|
Decompression, Surgical | 1 | 2010 | 55 | 0.040 |
Why?
|
Membranes | 1 | 1999 | 10 | 0.040 |
Why?
|
Forearm | 1 | 1999 | 43 | 0.040 |
Why?
|
Cartilage | 1 | 1999 | 32 | 0.040 |
Why?
|
Receptors, Adrenergic | 1 | 1998 | 7 | 0.040 |
Why?
|
Injections | 2 | 2011 | 64 | 0.040 |
Why?
|
Receptors, Adrenergic, beta | 1 | 1998 | 11 | 0.040 |
Why?
|
Bone Neoplasms | 2 | 1997 | 111 | 0.040 |
Why?
|
Receptors, Adrenergic, alpha-2 | 1 | 1998 | 33 | 0.040 |
Why?
|
Osteosarcoma | 1 | 1997 | 11 | 0.040 |
Why?
|
Nitric Oxide | 1 | 1998 | 112 | 0.040 |
Why?
|
Fibula | 1 | 1997 | 14 | 0.040 |
Why?
|
Skin Transplantation | 1 | 1997 | 49 | 0.040 |
Why?
|
Tibia | 1 | 1997 | 56 | 0.040 |
Why?
|
Cross-Sectional Studies | 2 | 2002 | 1530 | 0.040 |
Why?
|
Wounds, Gunshot | 1 | 1997 | 34 | 0.040 |
Why?
|
Oxacillin | 1 | 1997 | 4 | 0.040 |
Why?
|
Hydrogels | 2 | 2008 | 121 | 0.040 |
Why?
|
Duodenum | 1 | 1997 | 19 | 0.040 |
Why?
|
Penicillins | 1 | 1997 | 11 | 0.040 |
Why?
|
Perfusion | 2 | 1996 | 73 | 0.040 |
Why?
|
Intestinal Obstruction | 1 | 1997 | 12 | 0.040 |
Why?
|
Venules | 2 | 1998 | 5 | 0.040 |
Why?
|
Surgical Wound Infection | 1 | 1997 | 86 | 0.040 |
Why?
|
Arterioles | 2 | 1998 | 13 | 0.040 |
Why?
|
Clonidine | 2 | 2000 | 61 | 0.030 |
Why?
|
Extremities | 1 | 2016 | 51 | 0.030 |
Why?
|
Fracture Healing | 1 | 1997 | 45 | 0.030 |
Why?
|
Activities of Daily Living | 1 | 1998 | 259 | 0.030 |
Why?
|
Statistics, Nonparametric | 2 | 2011 | 131 | 0.030 |
Why?
|
Blood Flow Velocity | 2 | 1993 | 76 | 0.030 |
Why?
|
Nicotine | 1 | 1998 | 171 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2002 | 771 | 0.030 |
Why?
|
Smoking Cessation | 1 | 1998 | 197 | 0.030 |
Why?
|
Soft Tissue Neoplasms | 1 | 2016 | 39 | 0.030 |
Why?
|
Sex Factors | 1 | 1998 | 663 | 0.030 |
Why?
|
Nerve Transfer | 1 | 2015 | 17 | 0.030 |
Why?
|
Young Adult | 2 | 2015 | 2615 | 0.030 |
Why?
|
Fractures, Closed | 1 | 2015 | 9 | 0.030 |
Why?
|
Drug Utilization | 1 | 2015 | 49 | 0.030 |
Why?
|
Prognosis | 2 | 2015 | 1505 | 0.030 |
Why?
|
Diabetic Angiopathies | 1 | 2015 | 143 | 0.030 |
Why?
|
Tolonium Chloride | 1 | 2013 | 2 | 0.030 |
Why?
|
Myelin Sheath | 1 | 2013 | 12 | 0.030 |
Why?
|
Cohort Studies | 1 | 1998 | 1831 | 0.030 |
Why?
|
Antibodies | 1 | 2013 | 52 | 0.030 |
Why?
|
Locomotion | 1 | 1993 | 31 | 0.030 |
Why?
|
Norepinephrine | 3 | 1998 | 77 | 0.030 |
Why?
|
Xylazine | 1 | 1993 | 1 | 0.030 |
Why?
|
Nails | 1 | 2013 | 6 | 0.030 |
Why?
|
Injections, Intradermal | 1 | 2012 | 6 | 0.030 |
Why?
|
Hemodynamics | 1 | 1994 | 155 | 0.030 |
Why?
|
Retreatment | 1 | 2012 | 41 | 0.030 |
Why?
|
Anesthesia, Conduction | 1 | 2012 | 25 | 0.030 |
Why?
|
Analgesics, Opioid | 1 | 2015 | 231 | 0.030 |
Why?
|
Anesthesia | 1 | 1993 | 64 | 0.030 |
Why?
|
Yohimbine | 1 | 2012 | 4 | 0.030 |
Why?
|
Tetrodotoxin | 1 | 2012 | 11 | 0.030 |
Why?
|
Pulsatile Flow | 1 | 1992 | 26 | 0.030 |
Why?
|
Evoked Potentials, Motor | 1 | 2011 | 8 | 0.030 |
Why?
|
Rheology | 1 | 1992 | 30 | 0.030 |
Why?
|
Aorta, Abdominal | 1 | 1992 | 29 | 0.030 |
Why?
|
Albuterol | 1 | 1992 | 21 | 0.030 |
Why?
|
Authorship | 1 | 2011 | 9 | 0.020 |
Why?
|
Biopsy | 1 | 2013 | 260 | 0.020 |
Why?
|
Catheterization, Peripheral | 1 | 1992 | 29 | 0.020 |
Why?
|
Research Support as Topic | 1 | 2011 | 26 | 0.020 |
Why?
|
Vasodilation | 1 | 2012 | 93 | 0.020 |
Why?
|
Elastic Modulus | 1 | 2011 | 28 | 0.020 |
Why?
|
Motor Activity | 1 | 2013 | 325 | 0.020 |
Why?
|
Cattle | 1 | 2011 | 103 | 0.020 |
Why?
|
Probability | 1 | 2011 | 158 | 0.020 |
Why?
|
Radionuclide Imaging | 2 | 1993 | 26 | 0.020 |
Why?
|
Organ Size | 1 | 2011 | 210 | 0.020 |
Why?
|
Metacarpophalangeal Joint | 1 | 1990 | 3 | 0.020 |
Why?
|
Arthrodesis | 1 | 1990 | 20 | 0.020 |
Why?
|
Bone Screws | 1 | 1990 | 57 | 0.020 |
Why?
|
Preoperative Care | 1 | 2011 | 115 | 0.020 |
Why?
|
Computer Simulation | 1 | 2011 | 221 | 0.020 |
Why?
|
Collagen | 1 | 2011 | 225 | 0.020 |
Why?
|
Accidental Falls | 1 | 2011 | 221 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2011 | 594 | 0.020 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2008 | 29 | 0.020 |
Why?
|
Anti-Dyskinesia Agents | 1 | 2008 | 5 | 0.020 |
Why?
|
Sural Nerve | 1 | 2008 | 28 | 0.020 |
Why?
|
Anti-Infective Agents, Local | 1 | 2008 | 15 | 0.020 |
Why?
|
Adrenergic alpha-Antagonists | 2 | 1998 | 24 | 0.020 |
Why?
|
Ethics, Professional | 1 | 2008 | 8 | 0.020 |
Why?
|
Freezing | 1 | 2007 | 4 | 0.020 |
Why?
|
Adrenergic alpha-Agonists | 2 | 1998 | 42 | 0.020 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2007 | 13 | 0.020 |
Why?
|
Hip Dislocation, Congenital | 1 | 1987 | 8 | 0.020 |
Why?
|
Porosity | 1 | 2007 | 38 | 0.020 |
Why?
|
Professional-Patient Relations | 1 | 2008 | 25 | 0.020 |
Why?
|
Vasodilator Agents | 1 | 1988 | 61 | 0.020 |
Why?
|
Blood Pressure | 1 | 1992 | 845 | 0.020 |
Why?
|
Societies, Medical | 1 | 2008 | 162 | 0.020 |
Why?
|
Sarcomeres | 1 | 2006 | 3 | 0.020 |
Why?
|
Cell Line | 1 | 2007 | 435 | 0.020 |
Why?
|
Bone Lengthening | 1 | 1986 | 4 | 0.020 |
Why?
|
Ankle Joint | 1 | 2006 | 35 | 0.020 |
Why?
|
Risk Assessment | 1 | 2011 | 1435 | 0.020 |
Why?
|
Myogenic Regulatory Factor 5 | 1 | 2005 | 7 | 0.020 |
Why?
|
Trans-Activators | 1 | 2005 | 46 | 0.020 |
Why?
|
Synaptosomal-Associated Protein 25 | 1 | 2005 | 6 | 0.020 |
Why?
|
Muscle Proteins | 1 | 2005 | 59 | 0.020 |
Why?
|
Protein Subunits | 1 | 2005 | 34 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1985 | 82 | 0.020 |
Why?
|
Body Weights and Measures | 1 | 2004 | 24 | 0.020 |
Why?
|
Age Factors | 1 | 2008 | 1194 | 0.020 |
Why?
|
Clinical Competence | 1 | 2008 | 333 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2005 | 147 | 0.020 |
Why?
|
Dystonic Disorders | 1 | 2004 | 12 | 0.010 |
Why?
|
Baseball | 1 | 2005 | 41 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2001 | 1324 | 0.010 |
Why?
|
Diazepam | 1 | 2003 | 5 | 0.010 |
Why?
|
Muscle Relaxants, Central | 1 | 2003 | 6 | 0.010 |
Why?
|
Baclofen | 1 | 2003 | 12 | 0.010 |
Why?
|
Injections, Spinal | 1 | 2003 | 108 | 0.010 |
Why?
|
Methods | 2 | 1996 | 11 | 0.010 |
Why?
|
Bone Wires | 1 | 2002 | 11 | 0.010 |
Why?
|
Pulse | 1 | 2002 | 10 | 0.010 |
Why?
|
Drug Utilization Review | 1 | 2002 | 17 | 0.010 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2002 | 46 | 0.010 |
Why?
|
Drug Costs | 1 | 2002 | 47 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2002 | 186 | 0.010 |
Why?
|
Ethanol | 1 | 2003 | 186 | 0.010 |
Why?
|
Piperazines | 1 | 2000 | 54 | 0.010 |
Why?
|
Ultrasonography, Interventional | 1 | 2000 | 53 | 0.010 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 1998 | 18 | 0.010 |
Why?
|
Carbon Monoxide | 1 | 1998 | 9 | 0.010 |
Why?
|
Graft Rejection | 1 | 2000 | 238 | 0.010 |
Why?
|
Graft Survival | 1 | 2000 | 314 | 0.010 |
Why?
|
Dogs | 1 | 1998 | 120 | 0.010 |
Why?
|
Medetomidine | 1 | 1998 | 2 | 0.010 |
Why?
|
Propranolol | 1 | 1998 | 16 | 0.010 |
Why?
|
Administration, Cutaneous | 1 | 1998 | 116 | 0.010 |
Why?
|
Adrenergic beta-Antagonists | 1 | 1998 | 61 | 0.010 |
Why?
|
Imidazoles | 1 | 1998 | 91 | 0.010 |
Why?
|
Receptors, Adrenergic, alpha | 1 | 1996 | 2 | 0.010 |
Why?
|
Patient Compliance | 1 | 1998 | 224 | 0.010 |
Why?
|
Vasoconstrictor Agents | 1 | 1996 | 63 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 1996 | 80 | 0.010 |
Why?
|
Vena Cava, Inferior | 1 | 1996 | 32 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 1996 | 151 | 0.010 |
Why?
|
Bioprosthesis | 1 | 1996 | 58 | 0.010 |
Why?
|
Capillaries | 1 | 1994 | 24 | 0.010 |
Why?
|
Technetium | 1 | 1993 | 4 | 0.010 |
Why?
|
Reperfusion Injury | 1 | 1994 | 49 | 0.010 |
Why?
|
Bone and Bones | 1 | 1993 | 94 | 0.010 |
Why?
|
Shoulder Fractures | 1 | 1988 | 5 | 0.000 |
Why?
|